astragaloside a has been researched along with Age-Related Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Y; Gou, J; He, H; Kong, J; Shang, L; Sun, R; Tang, X; Tao, X; Wang, Y; Yin, T; Zhang, A; Zhang, G; Zhang, Y | 1 |
1 other study(ies) available for astragaloside a and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Topics: Animals; Apoptosis; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Nanocapsules; Ophthalmic Solutions; Phospholipids; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retinal Pigment Epithelium; Saponins; Triterpenes | 2020 |